From the Guidelines
For a woman with cholelithiasis but not cholestasis, the primary focus should be on preventing future biliary pain or complications, with a strong consideration for expectant management if asymptomatic, as recommended by the American College of Physicians 1. When managing cholelithiasis, it's crucial to differentiate between asymptomatic and symptomatic cases.
- Asymptomatic gallstones typically warrant expectant management, given the low risk of major complications and the potential risks associated with surgical or nonsurgical interventions 1.
- For symptomatic gallstones, the approach is more complex, involving an assessment of the patient's treatment goals, attitudes towards preventing another episode of pain, and the natural history of the disease 1. Key teaching points for a woman with cholelithiasis include:
- Dietary modifications to reduce the risk of triggering biliary pain, such as a low-fat diet and avoiding fatty or fried foods.
- Symptom management strategies, including the use of acetaminophen for pain relief during attacks.
- The importance of gradual weight loss, if necessary, to avoid rapid changes that could increase stone formation.
- Encouragement of regular physical activity to maintain a healthy weight and potentially reduce symptoms.
- Education on recognizing signs of complications, such as severe pain, fever, jaundice, or vomiting, which necessitate immediate medical attention. Given the potential for asymptomatic gallstones to remain benign, and the risks associated with intervention, a conservative approach is often recommended, unless specific risk factors for complications, such as gallbladder cancer, are identified 1.
From the FDA Drug Label
Although liver injury has not been associated with ursodiol therapy, a reduced capacity to sulfate may exist in some individuals, but such a deficiency has not yet been clearly demonstrated. Ursodiol suppresses hepatic synthesis and secretion of cholesterol, and also inhibits intestinal absorption of cholesterol The overall effect of ursodiol is to increase the concentration level at which saturation of cholesterol occurs The various actions of ursodiol combine to change the bile of patients with gallstones from cholesterol-precipitating to cholesterol-solubilizing, thus resulting in bile conducive to cholesterol stone dissolution.
For a woman with cholelithiasis but not cholestasis, some important teaching points include:
- Ursodiol therapy can help dissolve gallstones by changing the bile composition to be more conducive to cholesterol solubilization.
- The goal of ursodiol treatment is to increase the concentration level at which cholesterol saturation occurs, making it less likely for stones to form.
- Monitoring for stone recurrence is essential, and serial ultrasonographic examinations should be obtained.
- Diet and lifestyle modifications may also be necessary to prevent gallstone formation, especially in obese patients undergoing rapid weight loss 2.
- It is essential to follow the prescribed dosage and treatment duration to achieve the best results and minimize the risk of stone recurrence.
- Patients should be aware of the potential for stone recurrence after dissolution with ursodiol therapy and the importance of ongoing monitoring.
From the Research
Important Teaching Points for a Woman with Cholelithiasis
- Cholelithiasis affects approximately 15% of the US population, with women being more likely to experience it than men 3.
- Risk factors for cholelithiasis include pregnancy, increasing parity, and obesity during pregnancy 3.
- The classic presentation of cholelithiasis is right upper quadrant pain of the abdomen, often elicited upon palpation during physical examination and documented as a positive Murphy's sign 3.
- Referred pain to the right supraclavicular region and/or shoulder, nausea, and vomiting are also frequently reported by persons with cholelithiasis 3.
- Complications of cholelithiasis include cholecystitis (inflammation of the gallbladder) and cholangitis (inflammation of the bile duct) 3, 4.
Diagnosis and Management
- Ultrasonography is the gold standard for diagnosis of cholelithiasis 3.
- Management is dependent on severity and frequency of symptoms, and may include lifestyle and dietary modifications, medication management, and laparoscopic cholecystectomy 3, 5.
- Individuals with an established diagnosis of cholelithiasis should be referred to a surgeon and/or gastroenterologist within 2 weeks of initial presentation, regardless of severity or frequency of symptoms 3.
- Laparoscopic cholecystectomy has been shown to be an effective treatment for cholelithiasis, promoting symptom relief, reducing hospitalization duration, decreasing the incidence of complications, and improving quality of life 5.
Considerations for Clinical Care
- Standardized guidelines and objective scoring systems are important for improving quality, consistency, and compatibility across healthcare providers, and for improving patient outcomes and cost-efficacy 6.
- Opportunities exist for standardization in areas such as diagnosis, treatment outcomes, surgical risk factors, quality of life, and cost-efficacy 6.